皮瓣移植术后血管痉挛机制与解痉挛药物研究进展

马启明, 庄跃宏

中国临床解剖学杂志 ›› 2020, Vol. 38 ›› Issue (2) : 231-234.

中国临床解剖学杂志 ›› 2020, Vol. 38 ›› Issue (2) : 231-234. DOI: 10.13418/j.issn.1001-165x.2020.02.027
综述

皮瓣移植术后血管痉挛机制与解痉挛药物研究进展

  • 马启明 综述, 庄跃宏 审校
作者信息 +

Research progress on vasospasm mechanism and anti-vasospasm drugs after flap transplantation

  • MA Qi-ming,ZHUANG Yue-hong
Author information +
文章历史 +

引用本文

导出引用
马启明, 庄跃宏. 皮瓣移植术后血管痉挛机制与解痉挛药物研究进展[J]. 中国临床解剖学杂志. 2020, 38(2): 231-234 https://doi.org/10.13418/j.issn.1001-165x.2020.02.027
MA Qi-ming, ZHUANG Yue-hong. Research progress on vasospasm mechanism and anti-vasospasm drugs after flap transplantation[J]. Chinese Journal of Clinical Anatomy. 2020, 38(2): 231-234 https://doi.org/10.13418/j.issn.1001-165x.2020.02.027
中图分类号:      R628    R619.9   

参考文献

[1]  徐达传, 钟世镇. 深入开展基础与临床研究促进皮瓣外科的进一步发展[J]. 中国临床解剖学杂志, 2004, 22(1):3-4.
[2]  任振虎, 吴汉江, 谭宏宇, 等. 35例股前外侧游离皮瓣血管危象临床分析[J]. 上海口腔医学, 2016, 25(1):112-116.
[3] Vargas CR, Iorio ML, Lee BT. A systematic review of topical vasodilators for the treatment of intraoperative vasospasm in reconstructive microsurgery[J]. Plast Reconstr Surg, 2015, 136(2):411-422.
[4] Yu JT, Patel AJ, Malata CM. The use of topical vasodilators in microvascular surgery[J]. J Plast Reconstr Aesthet Surg, 2011, 64(2):226-228.
[5] Gradin KA, Buus CL, Li JY, et al. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats[J]. Br J Pharmacol, 2006, 148(5):703-713.
[6] Iartsev VN, Karachentseva OV, Dvaretskii DP. Potentiative effects of noradrenaline on the neurogenic vasoreactivity diminished by cooling[J]. Ross Fiziol Zh Im I M Sechenova, 2013, 99(8):960-967.
[7]  WIER W G, MAUBAN J R H. Imaging sympathetic neurogenic Ca(2+) signaling in blood vessels[J]. Auton Neurosci, 2017, 207(1):59-66.
[8] Haeren RHL, Hartmans SA, De Mey J, et al. Cerebral artery vasoconstriction is endothelin-1 dependent requiring neurogenic and adrenergic crosstalk[J]. Curr Neurovasc Res, 2017, 14(4):306-315.
[9] Iartsev VN, Karachentseva OV, Dvaretskii DP. Comparative analysis of the potentiative effect of noradrenaline on the neurogenic vasoconstriction diminished by various factors[J]. Ross Fiziol Zh Im I M Sechenova, 2015, 101(1):54-63.
[10]Su J, Laursen BE, Eskildsen-Helmond Y, et al. The vascular-disrupting agent, combretastatin-A4-phosphate, enhances neurogenic vasoconstriction in rat small arteries[J]. Eur J Pharmacol, 2012, 695(1-3):104-111.
[11]Yokoyama Y, Matsushita S, Iesaki T, et al. Denervation of gastroepiploic artery graft can reduce vasospasm[J]. J Thorac Cardiovasc Surg, 2014, 147(3):951-955.
[12]Walsh MP. Vascular smooth muscle myosin light chain diphosphorylation: mechanism, function, and pathological implications[J]. IUBMB Life, 2011, 63(11):987-1000.
[13]Hirano K. Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle[J]. J Pharmacol Sci, 2007, 104(2):109-115.
[14]Zhu Y, Qu J, He L, et al. Calcium in vascular smooth muscle cell elasticity and adhesion: novel insights into the mechanism of action[J]. Front Physiol, 2019, 10(1):852-852.
[15]Schubert R, Lidington D, Bolz SS. The emerging role of Ca2+ sensitivity regulation in promoting myogenic vasoconstriction[J]. Cardiovasc Res, 2008, 77(1):8-18.
[16]Hyza P, Streit L, Schwarz D, et al. Vasospasm of the flap pedicle: the effect of 11 of the most often used vasodilating drugs. Comparative study in a rat model[J]. Plast Reconstr Surg, 2014, 134(4):574e-584e.
[17]李婕. 妊娠期高血压疾病的中医证候特点及RGS2调节子宫动脉血管肌源性反应机制初探[D]. 南京中医药大学, 2016.
[18]Tanyeli O, Duman I, Dereli Y, et al. Relaxation matters: comparison of in-vitro vasodilatory role of botulinum toxin-A and papaverine in human radial artery grafts[J]. J Cardiothorac Surg, 2019, 14(1):15.
[19]Kaya B, Elcin Isilgan S, Serel S, et al. Metamizole: an effective solution for vasospasm[J]. J Plast Surg Hand Surg, 2016, 50(3):151-155.
[20]Lin Y, He JF, Zhang X, et al. Intraoperative factors associated with free flap failure in the head and neck region: a four-year retrospective study of 216 patients and review of the literature[J]. Int J Oral Maxillofac Surg, 2019, 48(4):447-451.
[21]Tang Y, Zhou C, Luan J, et al. Improvement of length of survival of expanded flap by application of topical papaverine cream[J]. J Plast Surg Hand Surg, 2012, 46(6):389-3 92.
[22]陈晓娟. 脑梗塞治疗中血管扩张剂的临床疗效及安全性[J]. 医学信息, 2013, 13(13):187-188.
[23]冷冰, 李荷欢, 韩思源,等. 己酮可可碱对随意皮瓣坏死率及血液流变性影响的实验研究[J]. 中国美容整形外科杂志, 2010, 21(12):764-766.
[24]邵洪波, 姚月明, 张庆富, 等. 己酮可可碱干预随意皮瓣的成活 激光多普勒血液灌流成像评价[J]. 中国组织工程研究, 2010, 14(5):838-842.
[25]Ichioka S, Nakatsuka T, Ohura N, et al. Topical application of amrinone (a selective phosphodiesterase III inhibitor) for relief of vasospasm[J]. J Surg Res, 2000, 93(1):149-155.
[26]Ichioka S, Nakatsuka T, Ohura N, et al. Clinical use of amrinone (a selective phosphodiesterase III inhibitor) in reconstructive surgery[J]. Plast Reconstr Surg, 2001, 108(7):1931-1937.
[27]Manno EM. Magnesium sulphate and cerebral vasospasm[J]. Lancet Neurol, 2005, 4(6):329-330.
[28]励钢. 血管吻合后顽固痉挛的处理[J]. 实用骨科杂志, 1995, 2(2):103-103.
[29]Evans GR, Gherardini G, Gurlek A, et al. Drug-induced vasodilation in an in vitro and in vivo study: the effects of nicardipine, papaverine, and lidocaine on the rabbit carotid artery[J]. Plast Reconstr Surg, 1997, 100(6):1475-1481.
[30]张显强, 刘胜初, 廖驭国, 等. 动脉内灌注维拉帕米治疗脑血管痉挛[J]. 中国微侵袭神经外科杂志, 2016, 21(1):31-33.
[31]Burma O, Ozcan M, Kacar E, et al. In vitro effects of sodium nitroprusside and leptin on norepinephrine-induced vasoconstriction in human internal mammary artery[J]. Cardiovasc J Afr, 2015, 26(1):4-7.
[32]杨钧, 钱涛. 前列腺素E1在面肌痉挛显微血管减压术围手术期作用临床观察[C]. 中华医学会神经外科学学术会议, 2011.
[33]Zhang JX, Gray J, Lalonde DH, et al. Digital necrosis after lidocaine and epinephrine injection in the flexor tendon sheath without phentolamine rescue[J]. J Hand Surg Am, 2017, 42(2):e119-e123.
[34]Van beek AL, Lim PK, Gear AJ, et al. Management of vasospastic disorders with botulinum toxin A[J]. Plast Reconstr Surg, 2007, 119(1):217-226.
[35]Neumeister MW, Webb KN, Romanelli M. Minimally invasive treatment of raynaud phenomenon: the role of botulinum type A[J]. Hand Clin, 2014, 30(1):17-24.
[36]Wegrzyn P, Lis G, Rudzinski P, et al. Vasodilatory efficacy and impact of papaverine on endothelium in radial artery predilatation for CABG surgery: in search for optimal concentration[J]. Braz J Cardiovasc Surg, 2018, 33(6):553-558.
[37]Zhou X, Alambyan V, Ostergard T, et al. Prolonged intracisternal papaverine toxicity: index case description and proposed mechanism of action[J]. World Neurosurg, 2018, 109(1):251-257.
[38]Wu EM, El ahmadieh TY, Kafka B, et al. Milrinone-associated cardiomyopathy and arrhythmia in cerebral vasospasm[J]. World Neurosurg, 2018, 114(1):252-256.
[39]Sakurada S, Takuwa N, Sugimoto N, et al. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction[J]. Circ Res, 2003, 93(6):548-556.
[40]Karaki H, Ahn HY, Urakawa N. Hyperosmotic applications of KCl induce vascular smooth muscle contraction which is independent of external Ca[J]. Jpn J Pharmacol, 1983, 33(1):246-248.
[41]Preez JF, Sanderson MJ. The frequency of calcium oscillations induced by 5-HT, ACH, and KCl determine the contraction of smooth muscle cells of intrapulmonary bronchioles[J]. J Gen Physiol, 2005, 125(6):535-553.
[42]Yavuz C, Callskan A, Karahan O, et al. Evaluation of the vasoplegic impact of papaverine in the rat aorta[J]. J Pak Med Assoc, 2014, 64(6):660-663.
[43]Zhou Y, Liu Y, Hao Y, et al. The mechanism of botulinum A on Raynaud syndrome[J]. Drug Des Devel Ther, 2018, 12(1):1905-1915.
[44]Yokoyama T, Kadota S, Takeuchi K, et al. Changes in the blood flow and prevention of vasospasm of the femoral artery by topical application of lidocaine in rats[J]. Ann Plast Surg, 2011, 67(2):178-183.
[45]Samuelson UE, Heden P, Jernbeck J, et al. Endothelin reduces blood flow in experimental skin flaps[J]. Scand J Plast Reconstr Surg Hand Surg, 1992, 26(3):241-245.

基金

福建省自然科学资金(2018J01831);科技创新联合资金项目(2017Y9112)

Accesses

Citation

Detail

段落导航
相关文章

/